ArticleAmerican journal of hematology2023

Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.

David J Gottlieb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.